Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Carmel, Indiana Clinical Trials

A listing of Carmel, Indiana clinical trials actively recruiting patient volunteers.

RESULTS

Found (6) clinical trials

Clinical Outcomes in Patients Treated With SternaLock Blu

The primary endpoint for this study is the rate of deep sternal wound infection (DSWI) at 30 days post-operative, following a midline sternotomy closed with SternaLock Blu. DSWI is defined as deep infection involving muscle, bone, and/ or mediastinum requiring operative intervention and has all of the following conditions: Wound ...

Phase N/A

0.0 miles

Learn More »

Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 2 study in subjects with moderate to severe Hidradenitis Suppurativa. The study is multicenter and will consist of three subject groups. Subjects will be randomized 1:1:1 to a treatment of 10mg avacopan twice daily, 30 mg avacopan twice daily or placebo twice daily ...

Phase

5.5 miles

Learn More »

Study of the Efficacy Safety and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin

A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin

Phase

5.5 miles

Learn More »

Study in Subjects With Moderate Atopic Dermatitis

The main objectives of this study are to: Evaluate the safety of ALX-101 Gel 5% when applied topically twice daily in subjects with moderate atopic dermatitis compared with a matching ALX-101 Gel Vehicle Evaluate the efficacy of ALX-101 Gel 5% when applied topically twice daily in subjects with moderate atopic ...

Phase

5.5 miles

Learn More »

Hydroxyurea Optimization Through Precision Study

The trial will recruit patients who have decided to initiate hydroxyurea therapy. All participants will have pharmacokinetics studies performed at baseline, following a 20 mg/kg oral dose of hydroxyurea. Pharmacokinetic sampling will use a sparse sampling approach, requiring collection of blood at 3 time points (15 minutes, 60 minutes, 180 ...

Phase

5.86 miles

Learn More »

A Study of the Efficacy and Safety of PXL770 Versus Placebo After 12 Weeks of Treatment in Patients With NAFLD

The study will be performed in patients with Nonalcoholic Fatty Liver Disease. The primary endpoint will be the assessment of the change in the percentage of liver fat mass (assessed by MRI-PDFF).

Phase

5.86 miles

Learn More »